Abstract:The aim of the present study was to investigate the relative bioavailability and bioequivalence of a new tablet formulation of metformin hydrochloride with reference to a standard product in healthy Chinese adult male volunteers. Two randomized, comparative, two-way crossover studies were therefore conducted. In study 1, which was a single-dose study, 20 subjects received 1000 mg metformin hydrochloride lest product extended-release (MXR) tablets followed by the same amount of metformin hydrochloride reference product immediate-release (MIR) tablets with a 7-day washout period between the two doses. In study 2, which was a multiple-dose study, 22 subjects received MXR 1000 mg/d for 9 consecutive days followed by MIR 1000 mg/d with a 14-day washout period between the doses of the test and reference product. The serum metformin concentrations were monitored using a selective and sensitive high-performance liquid chromatography (HPLC) method with ultraviolet (UV) detection. The pharmacokinetic parameters were calculated using a 3P97 program. Analysis of variance (ANOVA) of the half-life of the absorption phase (t1/2ka), the half-life of the elimination phase (t1/2kc) and the mean retention time (MRT) and the Wilcoxon Signed Rank test of Tmax for the two preparations were significantly different. A significant difference was found in the ANOVA for Cmax in the single-dose study, while this was not the case in the multiple-dose study. Two one-sided t-tests showed that there were no significant differences in the area under the concentration-time curve (AUC) values between the two formulations. The present study indicates that the test preparation was bioequivalent to the reference preparation when both MXR and MIR were investigated in healthy Chinese adult male volunteers. And on the basis of the mean AUC0−t, AUC0−∞ and AUCss, the relative bioavailability of the MXR was found to be 107.80%, 111.89% and 110.61% respectively compared with MIR.

Evaluation of Bioequivalence of Mirtazapine Tablets

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Determination of Mirtazapine in Human Plasma by HPLC-MS and Bioavailability of Newly Developed Mirtazapine Tablets in Healthy Volunteers

Study on Bioequivalence of Risperidone Tablets

Study on bioequivalence of trimetazidine capsule and tablet in healthy volunteers

Bioequivalent Study of Citalopram Tablets

Bioequivalence and Pharmacokinetics of Zolpidem Tartrate Mouth-dissolving Tablets

Relative Bioavailability and Bioequivalence of Metforphin Hydrochloride Extended-Released and Immediate-Released Tablets in Healthy Chinese Volunteers

Pharmacokinetics and Bioequivalence Study of Two Mosapride Citrate Formulations after Single-Dose Administration in Healthy Chinese Male Volunteers

Bioequivalence Study of Paroxetine Hydrochloride Film-Coated Tablets

Bioequivalence of Risperidone Orally Disintegrating Tablets in Healthy Volunteers

Bioequivalence of oral sertraline hydrochloride tablets and dispersible tabletsin healthy volunteers

Study on the bioequivalence of zolpidem tartrate in healthy Chinese vol unteers

Bioequivalence of cefprozil tablets in healthy volunteers

Study on Bioequivalence of Metronidazole Tablets

Bioequivalence of trimetazidine dihydrochloride tablets in Chinese healthy subjects

Pharmacokinetics and bioequivalence of topiramate tablets in healthy volunteers

Pharmacokinetics and bioequivalence of sertraline capsules and tablets

Pharmacokinetics and bioequivalence study of escitalopram oxalate formulations after single-dose administration in healthy Chinese male volunteers